{"result": "(\"entity\"<|>FEOCROMOCITOMA<|>EVENT<|>Feocromocitoma is a type of tumor that can secrete catecholamines and is often associated with genetic syndromes, presenting in various locations, particularly in the abdomen.)\n##\n(\"entity\"<|>SÍNDROME DE VON HIPPEL-LINDAU<|>ORGANIZATION<|>Syndrome associated with feocromocitomas, characterized by a hereditary autosomal dominant pattern and a 10-20% frequency of associated tumors.)\n##\n(\"entity\"<|>NEOPLASIA ENDOCRINA MÚLTIPLE TIPO 2<|>ORGANIZATION<|>A genetic disorder associated with a higher frequency of feocromocitomas, with a 50% occurrence rate in affected individuals.)\n##\n(\"entity\"<|>NEUROFIBROMATOSIS DE TIPO 1<|>ORGANIZATION<|>A genetic condition that is less commonly associated with feocromocitomas, with a 3% occurrence rate.)\n##\n(\"entity\"<|>SDHB<|>PERSON<|>A gene associated with susceptibility to feocromocitomas and paragangliomas, particularly in patients with mutations leading to a higher risk of tumors.)\n##\n(\"entity\"<|>SDHC<|>PERSON<|>A gene related to the development of feocromocitomas, often studied in genetic testing for patients with suspected tumors.)\n##\n(\"entity\"<|>VHL<|>PERSON<|>A gene associated with Von Hippel-Lindau syndrome, which increases the risk of developing feocromocitomas.)\n##\n(\"entity\"<|>SDHD<|>PERSON<|>A gene involved in the genetic predisposition to paragangliomas and feocromocitomas.)\n##\n(\"entity\"<|>TAC<|>EVENT<|>A medical imaging procedure used to detect tumors, particularly in the abdomen, with high sensitivity for small masses.)\n##\n(\"entity\"<|>CATECOLAMINAS<|>PERSON<|>Hormones that are often secreted by feocromocitomas, influencing the diagnosis and management of the condition.)\n##\n(\"relationship\"<|>SÍNDROME DE VON HIPPEL-LINDAU<|>FEOCROMOCITOMA<|>Feocromocitomas are commonly associated with Von Hippel-Lindau syndrome, which has a significant hereditary component<|>7)\n##\n(\"relationship\"<|>NEOPLASIA ENDOCRINA MÚLTIPLE TIPO 2<|>FEOCROMOCITOMA<|>Neoplasia Endocrina Múltiple Tipo 2 is associated with a high frequency of feocromocitomas, indicating a strong relationship<|>7)\n##\n(\"relationship\"<|>NEUROFIBROMATOSIS DE TIPO 1<|>FEOCROMOCITOMA<|>Neurofibromatosis Tipo 1 is less commonly associated with feocromocitomas, indicating a weaker relationship<|>3)\n##\n(\"relationship\"<|>SDHB<|>FEOCROMOCITOMA<|>Mutations in the SDHB gene are linked to an increased risk of developing feocromocitomas, indicating a strong relationship<|>8)\n##\n(\"relationship\"<|>SDHC<|>FEOCROMOCITOMA<|>SDHC mutations are also associated with feocromocitomas, suggesting a significant relationship<|>7)\n##\n(\"relationship\"<|>VHL<|>FEOCROMOCITOMA<|>The VHL gene is directly related to the development of feocromocitomas in patients with Von Hippel-Lindau syndrome<|>8)\n##\n(\"relationship\"<|>SDHD<|>FEOCROMOCITOMA<|>SDHD is associated with the risk of developing feocromocitomas, indicating a strong genetic link<|>7)\n##\n(\"relationship\"<|>TAC<|>FEOCROMOCITOMA<|>TAC is a diagnostic tool used to identify feocromocitomas in patients, indicating a direct relationship<|>9)\n##\n(\"relationship\"<|>CATECOLAMINAS<|>FEOCROMOCITOMA<|>Catecholamines are often secreted by feocromocitomas, making their measurement crucial for diagnosis<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: oplasias infrecuentes que probablemente suponen menos de 0,2% de los pacientes con hipertensión.\n\nLa mayoría de los feocromocitomas son esporádicos; sin embargo, aproximadamente el 40% de los pacientes tienen su enfermedad en el contexto de un síndrome familiar. En ese caso, los tumores se presentan a edades más tempranas que en los casos esporádicos.\n\nHay varios trastornos familiares asociados con feocromocitomas suprarrenales, todos ellos con una herencia autosómica dominante: síndrome de Von Hippel-Lindau, neoplasia endocrina múltiple tipo 2 y menos habitualmente la neurofibromatosis de tipo 1.\n---\n# SUPRARRENALES 5\n\nLa frecuencia de feocromocitoma asociado en estos trastornos es del 10-20% en el síndrome de Von Hippel-Lindau, del 50% en la neoplasia endocrina múltiple de tipo 2 y del 3% en la neurofibromatosis de tipo 1.\n\nAdemás, desde 1990 se han descrito 15 genes de susceptibilidad asociados a feocromocitomas y paragangliomas. Esos genes se han agrupado en dos grupos en función de la señal de transcripción que se afecta. De esta manera, tenemos un primer grupo que afecta a genes que codifican proteínas involucradas en la respuesta a la hipoxia y un segundo grupo relacionado con proteínas activadoras de la señal de quinasa. El primer grupo se relaciona con paragangliomas extraadrenales con la excepción del síndrome de Von Hippel-Lindau (los tumores suelen localizarse en la suprarrenal) y el segundo grupo se relaciona con feocromocitomas suprarrenales que presentan un fenotipo bioquímico suprarrenal.\n\nEl primer grupo incluye mutaciones germinales en SDHB, SDHC, SDHB, SDHAF2, SDHA, VHL, HIF2, FH gen codificante de fumarato hidratasa, EGLN1 (PHD2), EGLN2 (PHD1) y KIFB. El segundo grupo incluye mutaciones germinales en los genes RET, NF1, MAX y TMEM127.\n\nLa hipersecreción de catecolaminas asociada a paragangliomas dependerá de la localización de los mismos, de manera que solo son hipersecretores el 5% de los localizados en la base del cráneo y cuello, pero serán hipersecretores de catecolaminas más del 50% de los localizados en el abdomen.\n\nEl orden sugerido de estudio genético en caso de detectar un paraganglioma abdominal sería SDHB, SDHD, VHL y SDHC.\n\nLa inmunohistoquímica para SDHB de la pieza histológica puede servir para descartar mutaciones en SDHB, SDHC y SDHD, ya que, en caso de mutaciones en línea germinal, los tumores presentan una tinción ausente o en patrón difuso débil. Por lo tanto, en caso de ausencia de tinción será necesario el estudio genético, comenzando con SDHB.\n\nUna vez confirmado el exceso de producción de catecolaminas con los test bioquímicos se deben realizar las pruebas de imagen para la localización del tumor. Habitualmente, la primera prueba de imagen solicitada suele ser una TAC con contraste por su excelente resolución espacial, con una sensibilidad entre el 88% y 100% y que permite detectar tumores de hasta 5 mm.\n\nDebe recordarse que los pacientes con mutaciones en SDHB presentan más a menudo paragangliomas en tórax y abdomen, y en un 50% de los casos presentan metástasis a distancia. Otras patologías que pueden asociarse en caso de mutaciones en SDHB son cáncer renal, cáncer de tiroides y tumores del estroma gastrointestinal (GIST).\n\n## 5.8 Casos clínicos. Caso clínico 3\n\n### 55. Teniendo en cuenta el resultado de los análisis realizados y en espera de realización de pruebas de imagen, señale la opción falsa:\n\nA. El fenotipo bioquímico con secreción predominante de noradrenalina suele estar presente en pacientes con mutaciones del gen VHL y de SDHx.\nB. Los paragangliomas de cabeza y cuello en general no son productores de catecolaminas, por lo que es poco probable que el tumor esté localizado en el cuello.\nC. El perfil bioquímico orienta posiblemente a un MEN2.\nD. La mayoría de los feocromocitomas/paragangliomas se localizan en el abdomen.\n\n### 56. Se realiza TAC abdominal con los siguientes hallazgos: masas suprarrenales bilaterales que presentan marcado realce tras la administración de contraste intravenoso. A descartar feocromocitoma como primera posibilidad (lado izquierdo 2,4 × 3,3 cm y lado derecho 4,8\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}